By Kirsty Doolan
Galderma unveils global survey data at IMCAS 2026 revealing menopause-related skin care knowledge gap, skin changes and the growing role of aesthetic treatments in menopause skin care.
Key takeaways on Galderma’s menopause survey results
. A global Galderma survey reveals significant knowledge gaps around menopause-related skin changes.
. Galderma notes that declining oestrogen accelerates collagen, elastin and hyaluronic acid loss, impacting firmness, hydration and confidence.
. Aesthetic treatments show the highest satisfaction rates among women managing menopausal skin concerns.
. Galderma plans to include menopausal status in clinical trials to advance evidence-based aesthetic solutions.
At the International Master Course on Aging Science (IMCAS) 2026 World Congress in Paris on 30 January, pure-play skin care company Galderma will reveal key insights into how menopausal women are approaching menopause-related skin care and concerns.
Galderma’s survey, which will be presented as a poster at IMCAS, included more than 4,300 peri- and post-menopausal women aged 45- 60 from the United States, Brazil, Germany, the United Kingdom, Saudi Arabia, the United Arab Emirates, Egypt, China and Thailand, who have had or would be open to aesthetic treatments.
